Literature DB >> 2508983

Prostacyclin mediates antiaggregatory and hypotensive actions of endothelin in anaesthetized beagle dogs.

F Hermán1, K Magyar, P E Chabrier, P Braquet, J Filep.   

Abstract

The effects of endothelin on blood pressure and in vivo aggregation of platelets were studied in anaesthetized beagle dogs. Intravenous administration of endothelin (0.03-0.3 nmol kg-1) resulted in a dose-dependent transient hypotension followed by a long-lasting hypertension and inhibition of platelet aggregation. These changes were accompanied by dose-dependent elevation of plasma 6-keto prostaglandin F1 alpha levels. Pretreatment of the animals with acetylsalicylic acid significantly attenuated both the vascular and antiaggregatory responses to endothelin. These data provide evidence for in vivo release of prostacyclin by endothelin in anaesthetized dogs.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2508983      PMCID: PMC1854654          DOI: 10.1111/j.1476-5381.1989.tb16859.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  10 in total

1.  Integrated cardiac, renal, and endocrine actions of endothelin.

Authors:  W L Miller; M M Redfield; J C Burnett
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

2.  Cardiovascular, renal, and endocrine responses to intravenous endothelin in conscious dogs.

Authors:  K L Goetz; B C Wang; J B Madwed; J L Zhu; R J Leadley
Journal:  Am J Physiol       Date:  1988-12

3.  Endothelin inhibits ex vivo platelet aggregation in the rabbit.

Authors:  C Thiemermann; P Lidbury; R Thomas; J Vane
Journal:  Eur J Pharmacol       Date:  1988-12-06       Impact factor: 4.432

4.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells.

Authors:  M Yanagisawa; H Kurihara; S Kimura; Y Tomobe; M Kobayashi; Y Mitsui; Y Yazaki; K Goto; T Masaki
Journal:  Nature       Date:  1988-03-31       Impact factor: 49.962

5.  Extraction and chromatographic procedures for purification of prostaglandins, thromboxanes, prostacyclin, and their metabolites.

Authors:  K Gréen; M Hamberg; B Samuelsson; J C Frölich
Journal:  Adv Prostaglandin Thromboxane Res       Date:  1978

6.  Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor.

Authors:  G de Nucci; R Thomas; P D'Orleans-Juste; E Antunes; C Walder; T D Warner; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

7.  An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation.

Authors:  S Moncada; R Gryglewski; S Bunting; J R Vane
Journal:  Nature       Date:  1976-10-21       Impact factor: 49.962

8.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.

Authors:  R F Furchgott; J V Zawadzki
Journal:  Nature       Date:  1980-11-27       Impact factor: 49.962

9.  In vivo measurement of the disaggregatory action of prostacyclin. A methodological study.

Authors:  F Hermán; P Hadházy; K Magyar
Journal:  Thromb Res       Date:  1986-12-01       Impact factor: 3.944

10.  Activation of phospholipase A2 by endothelin in cultured vascular smooth muscle cells.

Authors:  T J Resink; T Scott-Burden; F R Bühler
Journal:  Biochem Biophys Res Commun       Date:  1989-01-16       Impact factor: 3.575

  10 in total
  7 in total

1.  Effects of indomethacin on the regional haemodynamic responses to low doses of endothelins and sarafotoxin.

Authors:  S M Gardiner; A M Compton; T Bennett
Journal:  Br J Pharmacol       Date:  1990-05       Impact factor: 8.739

2.  Role of ETB and B2 receptors in the ex vivo platelet inhibitory properties of endothelin and bradykinin in the mouse.

Authors:  J Labonté; I Brochu; J C Honoré; P D'Orléans-Juste
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

3.  Mediation of endothelin-1-induced inhibition of platelet aggregation via the ETB receptor.

Authors:  L McMurdo; P S Lidbury; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

4.  Endothelin-1-induced myocardial ischaemia and oedema in the rat: involvement of the ETA receptor, platelet-activating factor and thromboxane A2.

Authors:  J G Filep; A Fournier; E Földes-Filep
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

5.  Endothelins induce prostacyclin release in both vascular and non-vascular tissue.

Authors:  G G Mattera; R M Catalioto; M Criscuoli; A Subissi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-10       Impact factor: 3.000

6.  Different effects of endothelin-3 on the Ca2+ discharge induced by agonists and Ca(2+)-ATPase inhibitors in human platelets.

Authors:  C Astarie-Dequeker; I Korichneva; M A Devynck
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

7.  Effects of calcium antagonists on endothelin-1-induced myocardial ischaemia and oedema in the rat.

Authors:  J G Filep; Y Skrobik; A Fournier; E Földes-Filep
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.